Biosino Bio-Technology and Science Incorporation (08247.HK)

Biosino Bio-Technology & Science, Inc. engages in the manufacture, sale, and distribution of in-vitro diagnostic reagents and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 471 full-time employees. The company went IPO on 2006-02-27. The Company’s main products include clinical chemistry, immunological diagnostic products, molecular diagnostic products, hematology diagnostic products, medical clinical nutrition diagnostic products and related analytical instruments and raw materials. The Company’s products are mainly used for the diagnosis of liver function, lipids, renal function, myocardial, special proteins, trace elements, and sugar metabolism. The firm mainly operates its businesses in the domestic market.